ClinicalTrials.gg
CompletedNCT02793570Updated Nov 10, 2016

Non-contrast 3D MR Angiography for Assessment of the Thoracic Aorta in Pregnancy

An observational study in Magnetic Resonance Imaging and Pregnancy, sponsored by University Hospital Birmingham NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to female participants. Per ClinicalTrials.gov, last updated 2016-11-10.

Sponsored by University Hospital Birmingham NHS Foundation Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
15
Sex
Female
01

Study summary

Introduction: Native magnetic resonance angiography (MRA) is recommended to assess the thoracic aorta during pregnancy, avoiding the risks of ionising radiation and contrast agent administration. This guidance is however, based only on consensus opinion supported by limited case reports (level of evidence C).

Aim: To evaluate the feasibility of performing native 3D steady-state free-precession (SSFP) MRA in pregnant subjects with inherited aortopathy to guide timing and mode of delivery.

02

Conditions studied

  • Magnetic Resonance Imaging
  • Pregnancy
03

In context

Lead sponsor

University Hospital Birmingham NHS Foundation Trust is the lead sponsor of 36 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant subjects in mid-trimester with familial aortopathy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any pregnant subject with a history of familial aortopathy

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
15 participants (actual)
Patient registry
No

Interventions

  • Otherobservational
06

What researchers measure

Primary outcomes

  1. Gestation at delivery

    Time frame: 40 weeks

  2. Completion of non-contrast 3D MRA aorta

    Time frame: 40 weeks

07

Study locations

1 site
  • QEHB
    Birmingham, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02793570
Lead sponsor
University Hospital Birmingham NHS Foundation Trust
Responsible party
William E Moody (SpR Cardiology, University Hospital Birmingham NHS Foundation Trust) — Principal investigator
First posted
Jun 8, 2016
Start date
Jan 2015
Primary completion
Oct 2016
Completion
Oct 2016
Last update
Nov 10, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion